USFDA inspection at Goa facility ends with 5 procedural observations

Regulatory & Legal View source PDF Explain this filing

UNICHEMLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.9%Reaction day

₹548.50

prior close

₹546.20

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%-0.3% vs market

Pharmaceuticals peers, median of 172sector-1.5%-0.5% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

+0.2

15m

-0.2

30m

+0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.9-1.6-0.3-1.5-0.5

Next day

+3.0-0.6+3.6-1.0+4.0

-1.1-0.8-0.3-1.9+0.8

-3.0-2.1-0.9-2.4-0.6

-3.2-2.1-1.0-3.4+0.2

+0.3-0.8+1.1-2.4+2.7

-3.6-3.8+0.2-4.3+0.7

15d

-6.3-6.9+0.6-7.9+1.6

-10.9pendingpending-6.4-4.4

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

USFDA inspected Unichem Labs' Goa formulation facility at Pilerne, Bardez from 21 to 26 September 2026. The inspection closed with 5 observations classified by the company as procedural enhancements, not serious compliance failures. The company will submit its response to USFDA within the stipulated 15-day window.

Likely market impact

No critical compliance issues flagged; near-term stock impact likely limited unless the matter escalates to a warning letter.